Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci. - Wikidata - wikimedia - TriplyDB

Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.

Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.

http://www.wikidata.org/entity/Q39780025

about

Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance.Contribution of the 8-methoxy group to the activity of gatifloxacin against type II topoisomerases of Streptococcus pneumoniae.Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group.Contributions of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae.Enhancement of fluoroquinolone activity by C-8 halogen and methoxy moieties: action against a gyrase resistance mutant of Mycobacterium smegmatis and a gyrase-topoisomerase IV double mutant of Staphylococcus aureus.Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones.Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model.Effect of N-1/c-8 ring fusion and C-7 ring structure on fluoroquinolone lethality.Propensity of fluoroquinolones with different moieties at position 8 to cause resistance development in clinical isolates of Streptococcus pneumoniae.Contribution of the C-8-methoxy group of gatifloxacin to inhibition of type II topoisomerases of Staphylococcus aureus.Use of gyrase resistance mutants to guide selection of 8-methoxy-quinazoline-2,4-diones.

P2860

Q28343182-60356CF9-7C1F-430C-85D7-6D22A6BB2086 Q28369156-3A704EAE-C6A1-4A25-9E57-01E0F74EE131 Q33740527-6BDCFF7C-EAD3-4FDA-B607-1BE0460EFABB Q34721556-89EFD681-2753-4D54-97F3-013EA64171C7 Q39472413-7D18D2DA-C30A-4B9A-AA90-3AC92DA650F8 Q39477371-F1328229-1E4F-492A-96C8-B6105D206B03 Q39478440-468F72B5-DA18-490D-96DD-AA6B055B48FF Q39557560-0947663E-5BA0-498D-BEDF-8D717083BF43 Q39792565-8CAF9ACB-5E31-4B3B-A0BB-5FB5E9F15730 Q41911088-0A5DC707-6C9D-4385-BF2F-B9CFA00ED0CA Q42730708-93DC62D4-794E-40C0-B70A-84CE0E943A4F Q42784827-FE7E408C-DD5E-4998-B302-546DF296218D Q43251107-EFE5BA2F-9C45-443A-BBA1-F10581C78084

P2860

Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.

http://www.wikidata.org/entity/Q39780025

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

1995年學術文章

@zh

1995年學術文章

@zh-hant

name

Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.

@en

Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.

@nl

type

label

Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.

@en

Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.

@nl

prefLabel

Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.

@en

Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.

@nl

P1433

Q39780025-78CABFEF-1D8C-4C19-826E-980AB9D2C230

P1476

Q39780025-9DC25B1F-5728-47AF-B6CE-14B97C501CAE

P2093

Q39780025-54E19608-EA8C-4018-A5CC-3CE9C5880850

Q39780025-C73DCC2E-90E0-4652-8AF1-3D3F57545911

Q39780025-DC8F976A-0960-4366-85D1-83C2F30A94BB

P2860

Q39780025-088022FD-57DA-4080-94F5-F1362AC48808

Q39780025-10CCBCDB-8829-4594-AB37-FE757293586E

Q39780025-21D57394-C47D-4547-8E13-3531D070CEB0

Q39780025-26F7F80B-5118-48BD-BDD3-0E22D6F3CE6B

Q39780025-27E97309-6013-4554-8C54-115E5E045FA8

Q39780025-3ADC6195-7667-45E9-8D6A-794279C4F15E

Q39780025-4CA7928B-32C1-40B5-A09B-CE42D8B3DB8B

Q39780025-4F3C01D0-56BC-42E7-AF7D-1CA2660B5F21

Q39780025-6F4C540E-FCF0-4309-B3FA-E4356D39CFEB

Q39780025-7C2A4A96-E48E-4F96-B0F9-8774AEC368FF

P304

Q39780025-B829CE5D-590F-489C-984B-62F7EA39CD68

P31

Q39780025-E8137B07-FB33-432B-A161-9D77491E7EEC

P356

Q39780025-03FF50CF-FB83-407F-9E72-3763EA7B0C15

P407

Q39780025-9C81139C-10B4-4620-8338-C918A64CC182

P433

Q39780025-598706B2-E7BD-468A-8C3A-442CA9E9C5E8

P478

Q39780025-AB049D56-52C7-4A38-8953-0DF3ECB98F37

P577

Q39780025-C72138A4-D143-45E0-B956-2A05EA71CFE2

P5875

Q39780025-4956AF9A-2303-4084-A197-CBEE9C0FDEE7

P698

Q39780025-898BC252-5E98-4183-B946-83FA15619E8D

P921

Q39780025-570BCF1C-E8CD-422E-9030-BBF5BD95EE0E

P932

Q39780025-841AB13A-0A66-4F26-9307-A8CC836FDBCF

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.

@en

P2093

Ito T

http://www.w3.org/2001/XMLSchema#string

Matsumoto M

http://www.w3.org/2001/XMLSchema#string

Nishino T

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing.

In vitro antibacterial activity of Q-35, a new fluoroquinolone

In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.

Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital

A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus

Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrase A protein of Staphylococcus aureus and Staphylococcus epidermidis.

Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones.

In vitro activity of AT-4140 against clinical bacterial isolates.

Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones

Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus.

P304

1522-1525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.39.7.1522

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

1995-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15707198

http://www.w3.org/2001/XMLSchema#string

P698

7492097

http://www.w3.org/2001/XMLSchema#string

P921

P932

162774

http://www.w3.org/2001/XMLSchema#string